Text resize: A A A

milestones

1984 | 1986 | 1987 | 1990

Our first USFDA inspection was in 1987. This is when the world realised that not only were we able to produce and sell the drugs at those prices but we were also USFDA inspected. Dr. Reddy Laboratories and Cheminor were inspected in the same week, and both passed the inspections. These were the first USFDA inspections in Hyderabad. We knew we could sell our drugs in the US at premium prices.

Murali Divi
Currently, Chairman Divis Laboratories Was MD of Cheminor Drugs from 1984- 1990

Formulation Operations Begin. Obtains USFDA approval for Ibuprofen API

Formulation Operations begin with formation of Stangen Pharmaceuticals. KB Sankar Rao takes over as the production manager and TR Bhoopathy as the head of marketing of the company. Stangen Pharmaceuticals starts expanding its marketing network to Eastern, North Eastern, Northern and Central India.

1987 sees Cheminor Drugs obtain its first USFDA approval for Ibuprofen API. This marks the first inspection of the API facility at Jeedimetla, Hyderabad. The company also starts exporting Ibuprofen API to the U.S.A. Globe Organics, a subsidiary of Cheminor Drugs, starts operations. In the same year, Dr. Reddy’s obtains USFDA approval for Methyldopa.

It acquires Benzex Laboratories, a bulk drug unit in Bollarum, Hyderabad thus expanding its bulk actives business. Benzex starts manufacturing active ingredients of certain semi-synthetic Pencillins (Ampicillin and Cephalexin).

Click to read related memories

1987

The first Formulations Unit at Bollarum, Hyderabad. Commercial production starts in 1987.